1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose and Centriacinar Emphysema

1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose has been researched along with Centriacinar Emphysema in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Krisanarungson, P; Parasaram, V; Vyavahare, N; Wang, X	1

Other Studies

1 other study(ies) available for 1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose and Centriacinar Emphysema

Article	Year
Targeted delivery of pentagalloyl glucose inhibits matrix metalloproteinase activity and preserves elastin in emphysematous lungs. Respiratory research, 2021, Sep-18, Volume: 22, Issue:1 Topics: Administration, Inhalation; Animals; Dose-Response Relationship, Drug; Drug Delivery Systems; Elastin; Hydrolyzable Tannins; Male; Matrix Metalloproteinase 12; Matrix Metalloproteinase Inhibitors; Mice; Mice, Inbred C57BL; Pulmonary Emphysema; Tidal Volume	2021

Article

Year

Targeted delivery of pentagalloyl glucose inhibits matrix metalloproteinase activity and preserves elastin in emphysematous lungs.

Respiratory research, 2021, Sep-18, Volume: 22, Issue:1

Topics: Administration, Inhalation; Animals; Dose-Response Relationship, Drug; Drug Delivery Systems; Elastin; Hydrolyzable Tannins; Male; Matrix Metalloproteinase 12; Matrix Metalloproteinase Inhibitors; Mice; Mice, Inbred C57BL; Pulmonary Emphysema; Tidal Volume

2021